{"transactions":[{"id":2534343,"issuer":{"id":7122,"kind":"organization","name":"Xilio Therapeutics, Inc."},"owners":[{"id":117967,"kind":"organization","name":"Rock Springs Capital Management LP","position":1,"cik":"0001595725","reported_name":"Rock Springs Capital Management LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":131481,"kind":"organization","name":"Rock Springs Capital LLC","position":2,"cik":"0001735397","reported_name":"Rock Springs Capital LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":131482,"kind":"organization","name":"Rock Springs Capital Master Fund LP","position":3,"cik":"0001735393","reported_name":"Rock Springs Capital Master Fund LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":134213,"kind":"organization","name":"Four Pines Master Fund LP","position":4,"cik":"0001888685","reported_name":"Four Pines Master Fund LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Series C Preferred Stock","published_at":"2021-10-26T21:04:25.000Z","date":"2021-10-26","kind":"exercise","acquired":false,"shares":1437297,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"The Series C Preferred Stock converted into shares of the Issuer's common stock, $0.001 par value, on a 9.5:1 basis automatically immediately prior to the closing of the Issuer's initial public offering. The Series C Preferred Stock had no expiration date."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The Series C Preferred Stock converted into shares of the Issuer's common stock, $0.001 par value, on a 9.5:1 basis automatically immediately prior to the closing of the Issuer's initial public offering. The Series C Preferred Stock had no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The Series C Preferred Stock converted into shares of the Issuer's common stock, $0.001 par value, on a 9.5:1 basis automatically immediately prior to the closing of the Issuer's initial public offering. The Series C Preferred Stock had no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"The Series C Preferred Stock converted into shares of the Issuer's common stock, $0.001 par value, on a 9.5:1 basis automatically immediately prior to the closing of the Issuer's initial public offering. The Series C Preferred Stock had no expiration date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"The securities reported herein are held of record by Four Pines Master Fund LP (\"Four Pines\"). RSC is the general partner of RSCM which is the investment manager to Four Pines. RSC and RSCM may therefore be deemed to have or share beneficial ownership of the shares held directly by Four Pines."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":151294},"source":{"system":"sec-edgar","filing":"0001104659-21-130031","document":"tm2130646-27_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1595725/000110465921130031/tm2130646-27_4seq1.xml","form_type":"4"}},{"id":2534342,"issuer":{"id":7122,"kind":"organization","name":"Xilio Therapeutics, Inc."},"owners":[{"id":117967,"kind":"organization","name":"Rock Springs Capital Management LP","position":1,"cik":"0001595725","reported_name":"Rock Springs Capital Management LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":131481,"kind":"organization","name":"Rock Springs Capital LLC","position":2,"cik":"0001735397","reported_name":"Rock Springs Capital LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":131482,"kind":"organization","name":"Rock Springs Capital Master Fund LP","position":3,"cik":"0001735393","reported_name":"Rock Springs Capital Master Fund LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":134213,"kind":"organization","name":"Four Pines Master Fund LP","position":4,"cik":"0001888685","reported_name":"Four Pines Master Fund LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Series C Preferred Stock","published_at":"2021-10-26T21:04:25.000Z","date":"2021-10-26","kind":"exercise","acquired":false,"shares":7186490,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"The Series C Preferred Stock converted into shares of the Issuer's common stock, $0.001 par value, on a 9.5:1 basis automatically immediately prior to the closing of the Issuer's initial public offering. The Series C Preferred Stock had no expiration date."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The Series C Preferred Stock converted into shares of the Issuer's common stock, $0.001 par value, on a 9.5:1 basis automatically immediately prior to the closing of the Issuer's initial public offering. The Series C Preferred Stock had no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The Series C Preferred Stock converted into shares of the Issuer's common stock, $0.001 par value, on a 9.5:1 basis automatically immediately prior to the closing of the Issuer's initial public offering. The Series C Preferred Stock had no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"The Series C Preferred Stock converted into shares of the Issuer's common stock, $0.001 par value, on a 9.5:1 basis automatically immediately prior to the closing of the Issuer's initial public offering. The Series C Preferred Stock had no expiration date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The securities reported herein are held of record by Rock Springs Capital Master Fund LP (\"Master Fund\"). Rock Springs Capital LLC (\"RSC\") is the general partner of Rock Springs Capital Management LP (\"RSCM\") which is the investment manager to Master Fund. RSC and RSCM may therefore be deemed to have or share beneficial ownership of the shares held directly by Master Fund."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":756472},"source":{"system":"sec-edgar","filing":"0001104659-21-130031","document":"tm2130646-27_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1595725/000110465921130031/tm2130646-27_4seq1.xml","form_type":"4"}},{"id":2534341,"issuer":{"id":7122,"kind":"organization","name":"Xilio Therapeutics, Inc."},"owners":[{"id":117967,"kind":"organization","name":"Rock Springs Capital Management LP","position":1,"cik":"0001595725","reported_name":"Rock Springs Capital Management LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":131481,"kind":"organization","name":"Rock Springs Capital LLC","position":2,"cik":"0001735397","reported_name":"Rock Springs Capital LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":131482,"kind":"organization","name":"Rock Springs Capital Master Fund LP","position":3,"cik":"0001735393","reported_name":"Rock Springs Capital Master Fund LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":134213,"kind":"organization","name":"Four Pines Master Fund LP","position":4,"cik":"0001888685","reported_name":"Four Pines Master Fund LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2021-10-26T21:04:25.000Z","date":"2021-10-26","kind":"purchase","acquired":true,"shares":500000,"price":16,"value":8000000.0,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The securities reported herein are held of record by Rock Springs Capital Master Fund LP (\"Master Fund\"). Rock Springs Capital LLC (\"RSC\") is the general partner of Rock Springs Capital Management LP (\"RSCM\") which is the investment manager to Master Fund. RSC and RSCM may therefore be deemed to have or share beneficial ownership of the shares held directly by Master Fund."}],"balance_after":1256472,"source":{"system":"sec-edgar","filing":"0001104659-21-130031","document":"tm2130646-27_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1595725/000110465921130031/tm2130646-27_4seq1.xml","form_type":"4"}},{"id":2534340,"issuer":{"id":7122,"kind":"organization","name":"Xilio Therapeutics, Inc."},"owners":[{"id":117967,"kind":"organization","name":"Rock Springs Capital Management LP","position":1,"cik":"0001595725","reported_name":"Rock Springs Capital Management LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":131481,"kind":"organization","name":"Rock Springs Capital LLC","position":2,"cik":"0001735397","reported_name":"Rock Springs Capital LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":131482,"kind":"organization","name":"Rock Springs Capital Master Fund LP","position":3,"cik":"0001735393","reported_name":"Rock Springs Capital Master Fund LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":134213,"kind":"organization","name":"Four Pines Master Fund LP","position":4,"cik":"0001888685","reported_name":"Four Pines Master Fund LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2021-10-26T21:04:25.000Z","date":"2021-10-26","kind":"exercise","acquired":true,"shares":151294,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The Series C Preferred Stock converted into shares of the Issuer's common stock, $0.001 par value, on a 9.5:1 basis automatically immediately prior to the closing of the Issuer's initial public offering. The Series C Preferred Stock had no expiration date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"The securities reported herein are held of record by Four Pines Master Fund LP (\"Four Pines\"). RSC is the general partner of RSCM which is the investment manager to Four Pines. RSC and RSCM may therefore be deemed to have or share beneficial ownership of the shares held directly by Four Pines."}],"balance_after":151294,"source":{"system":"sec-edgar","filing":"0001104659-21-130031","document":"tm2130646-27_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1595725/000110465921130031/tm2130646-27_4seq1.xml","form_type":"4"}},{"id":2534339,"issuer":{"id":7122,"kind":"organization","name":"Xilio Therapeutics, Inc."},"owners":[{"id":117967,"kind":"organization","name":"Rock Springs Capital Management LP","position":1,"cik":"0001595725","reported_name":"Rock Springs Capital Management LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":131481,"kind":"organization","name":"Rock Springs Capital LLC","position":2,"cik":"0001735397","reported_name":"Rock Springs Capital LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":131482,"kind":"organization","name":"Rock Springs Capital Master Fund LP","position":3,"cik":"0001735393","reported_name":"Rock Springs Capital Master Fund LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":134213,"kind":"organization","name":"Four Pines Master Fund LP","position":4,"cik":"0001888685","reported_name":"Four Pines Master Fund LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2021-10-26T21:04:25.000Z","date":"2021-10-26","kind":"exercise","acquired":true,"shares":756472,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The Series C Preferred Stock converted into shares of the Issuer's common stock, $0.001 par value, on a 9.5:1 basis automatically immediately prior to the closing of the Issuer's initial public offering. The Series C Preferred Stock had no expiration date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The securities reported herein are held of record by Rock Springs Capital Master Fund LP (\"Master Fund\"). Rock Springs Capital LLC (\"RSC\") is the general partner of Rock Springs Capital Management LP (\"RSCM\") which is the investment manager to Master Fund. RSC and RSCM may therefore be deemed to have or share beneficial ownership of the shares held directly by Master Fund."}],"balance_after":756472,"source":{"system":"sec-edgar","filing":"0001104659-21-130031","document":"tm2130646-27_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1595725/000110465921130031/tm2130646-27_4seq1.xml","form_type":"4"}},{"id":2542470,"issuer":{"id":94301,"kind":"organization","name":"Theseus Pharmaceuticals, Inc.","symbol":"THRX"},"owners":[{"id":117967,"kind":"organization","name":"Rock Springs Capital Management LP","position":1,"cik":"0001595725","reported_name":"Rock Springs Capital Management LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":131482,"kind":"organization","name":"Rock Springs Capital Master Fund LP","position":2,"cik":"0001735393","reported_name":"Rock Springs Capital Master Fund LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":131481,"kind":"organization","name":"Rock Springs Capital LLC","position":3,"cik":"0001735397","reported_name":"Rock Springs Capital LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Series B Convertible Preferred Stock","published_at":"2021-10-14T17:00:28.000Z","date":"2021-10-12","kind":"exercise","acquired":false,"shares":87329,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"The reported security converted into the issuer's Common Stock on a one-for-one basis automatically immediately prior to the closing of the issuer's initial public offering without payment of further consideration. The shares have no expiration date."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The reported security converted into the issuer's Common Stock on a one-for-one basis automatically immediately prior to the closing of the issuer's initial public offering without payment of further consideration. The shares have no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The reported security converted into the issuer's Common Stock on a one-for-one basis automatically immediately prior to the closing of the issuer's initial public offering without payment of further consideration. The shares have no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The reported security converted into the issuer's Common Stock on a one-for-one basis automatically immediately prior to the closing of the issuer's initial public offering without payment of further consideration. The shares have no expiration date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"The securities reported herein are held of record by Four Pines Master Fund LP (\"Four Pines\"). RSC is the general partner of RSCM which is the investment manager to Four Pines. RSC and RSCM may therefore be deemed to have or share beneficial ownership of the shares held directly by Four Pines."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":87329},"source":{"system":"sec-edgar","filing":"0000899243-21-040255","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1745020/000089924321040255/doc4.xml","form_type":"4"}},{"id":2542469,"issuer":{"id":94301,"kind":"organization","name":"Theseus Pharmaceuticals, Inc.","symbol":"THRX"},"owners":[{"id":117967,"kind":"organization","name":"Rock Springs Capital Management LP","position":1,"cik":"0001595725","reported_name":"Rock Springs Capital Management LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":131482,"kind":"organization","name":"Rock Springs Capital Master Fund LP","position":2,"cik":"0001735393","reported_name":"Rock Springs Capital Master Fund LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":131481,"kind":"organization","name":"Rock Springs Capital LLC","position":3,"cik":"0001735397","reported_name":"Rock Springs Capital LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Series B Convertible Preferred Stock","published_at":"2021-10-14T17:00:28.000Z","date":"2021-10-12","kind":"exercise","acquired":false,"shares":349320,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"The reported security converted into the issuer's Common Stock on a one-for-one basis automatically immediately prior to the closing of the issuer's initial public offering without payment of further consideration. The shares have no expiration date."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The reported security converted into the issuer's Common Stock on a one-for-one basis automatically immediately prior to the closing of the issuer's initial public offering without payment of further consideration. The shares have no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The reported security converted into the issuer's Common Stock on a one-for-one basis automatically immediately prior to the closing of the issuer's initial public offering without payment of further consideration. The shares have no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The reported security converted into the issuer's Common Stock on a one-for-one basis automatically immediately prior to the closing of the issuer's initial public offering without payment of further consideration. The shares have no expiration date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"The securities reported herein are held of record by Rock Springs Capital Master Fund LP (\"Master Fund\"). Rock Springs Capital LLC (\"RSC\") is the general partner of Rock Springs Capital Management LP (\"RSCM\") which is the investment manager to Master Fund. RSC and RSCM may therefore be deemed to have or share beneficial ownership of the shares held directly by Master Fund."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":349320},"source":{"system":"sec-edgar","filing":"0000899243-21-040255","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1745020/000089924321040255/doc4.xml","form_type":"4"}},{"id":2542468,"issuer":{"id":94301,"kind":"organization","name":"Theseus Pharmaceuticals, Inc.","symbol":"THRX"},"owners":[{"id":117967,"kind":"organization","name":"Rock Springs Capital Management LP","position":1,"cik":"0001595725","reported_name":"Rock Springs Capital Management LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":131482,"kind":"organization","name":"Rock Springs Capital Master Fund LP","position":2,"cik":"0001735393","reported_name":"Rock Springs Capital Master Fund LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":131481,"kind":"organization","name":"Rock Springs Capital LLC","position":3,"cik":"0001735397","reported_name":"Rock Springs Capital LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2021-10-14T17:00:28.000Z","date":"2021-10-12","kind":"purchase","acquired":true,"shares":250000,"price":16,"value":4000000.0,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F5","text":"Represents shares purchased in the issuer's initial public offering."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"The securities reported herein are held of record by Rock Springs Capital Master Fund LP (\"Master Fund\"). Rock Springs Capital LLC (\"RSC\") is the general partner of Rock Springs Capital Management LP (\"RSCM\") which is the investment manager to Master Fund. RSC and RSCM may therefore be deemed to have or share beneficial ownership of the shares held directly by Master Fund."}],"balance_after":599320,"source":{"system":"sec-edgar","filing":"0000899243-21-040255","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1745020/000089924321040255/doc4.xml","form_type":"4"}},{"id":2542467,"issuer":{"id":94301,"kind":"organization","name":"Theseus Pharmaceuticals, Inc.","symbol":"THRX"},"owners":[{"id":117967,"kind":"organization","name":"Rock Springs Capital Management LP","position":1,"cik":"0001595725","reported_name":"Rock Springs Capital Management LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":131482,"kind":"organization","name":"Rock Springs Capital Master Fund LP","position":2,"cik":"0001735393","reported_name":"Rock Springs Capital Master Fund LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":131481,"kind":"organization","name":"Rock Springs Capital LLC","position":3,"cik":"0001735397","reported_name":"Rock Springs Capital LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2021-10-14T17:00:28.000Z","date":"2021-10-12","kind":"exercise","acquired":true,"shares":87329,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The total represents shares received upon conversion of shares of Series B Convertible Preferred Stock."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The reported security converted into the issuer's Common Stock on a one-for-one basis automatically immediately prior to the closing of the issuer's initial public offering without payment of further consideration. The shares have no expiration date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"The securities reported herein are held of record by Four Pines Master Fund LP (\"Four Pines\"). RSC is the general partner of RSCM which is the investment manager to Four Pines. RSC and RSCM may therefore be deemed to have or share beneficial ownership of the shares held directly by Four Pines."}],"balance_after":87329,"source":{"system":"sec-edgar","filing":"0000899243-21-040255","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1745020/000089924321040255/doc4.xml","form_type":"4"}},{"id":2542466,"issuer":{"id":94301,"kind":"organization","name":"Theseus Pharmaceuticals, Inc.","symbol":"THRX"},"owners":[{"id":117967,"kind":"organization","name":"Rock Springs Capital Management LP","position":1,"cik":"0001595725","reported_name":"Rock Springs Capital Management LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":131482,"kind":"organization","name":"Rock Springs Capital Master Fund LP","position":2,"cik":"0001735393","reported_name":"Rock Springs Capital Master Fund LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":131481,"kind":"organization","name":"Rock Springs Capital LLC","position":3,"cik":"0001735397","reported_name":"Rock Springs Capital LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2021-10-14T17:00:28.000Z","date":"2021-10-12","kind":"exercise","acquired":true,"shares":349320,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The total represents shares received upon conversion of shares of Series B Convertible Preferred Stock."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The reported security converted into the issuer's Common Stock on a one-for-one basis automatically immediately prior to the closing of the issuer's initial public offering without payment of further consideration. The shares have no expiration date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"The securities reported herein are held of record by Rock Springs Capital Master Fund LP (\"Master Fund\"). Rock Springs Capital LLC (\"RSC\") is the general partner of Rock Springs Capital Management LP (\"RSCM\") which is the investment manager to Master Fund. RSC and RSCM may therefore be deemed to have or share beneficial ownership of the shares held directly by Master Fund."}],"balance_after":349320,"source":{"system":"sec-edgar","filing":"0000899243-21-040255","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1745020/000089924321040255/doc4.xml","form_type":"4"}},{"id":2659203,"issuer":{"id":11259,"kind":"organization","name":"Verve Therapeutics, Inc.","symbol":"VERV"},"owners":[{"id":117967,"kind":"organization","name":"Rock Springs Capital Management LP","position":1,"cik":"0001595725","reported_name":"Rock Springs Capital Management LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":131482,"kind":"organization","name":"Rock Springs Capital Master Fund LP","position":2,"cik":"0001735393","reported_name":"Rock Springs Capital Master Fund LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":131481,"kind":"organization","name":"Rock Springs Capital LLC","position":3,"cik":"0001735397","reported_name":"Rock Springs Capital LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Series B Preferred Stock","published_at":"2021-06-22T17:20:53.000Z","date":"2021-06-21","kind":"exercise","acquired":false,"shares":1416023,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"The Series B Preferred Stock converted into shares of the Issuer's common stock, $0.001 par value, on an approximately 9.2595:1 basis automatically immediately prior to the closing of the Issuer's initial public offering. The Series B Preferred Stock had no expiration date."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The Series B Preferred Stock converted into shares of the Issuer's common stock, $0.001 par value, on an approximately 9.2595:1 basis automatically immediately prior to the closing of the Issuer's initial public offering. The Series B Preferred Stock had no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The Series B Preferred Stock converted into shares of the Issuer's common stock, $0.001 par value, on an approximately 9.2595:1 basis automatically immediately prior to the closing of the Issuer's initial public offering. The Series B Preferred Stock had no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"The Series B Preferred Stock converted into shares of the Issuer's common stock, $0.001 par value, on an approximately 9.2595:1 basis automatically immediately prior to the closing of the Issuer's initial public offering. The Series B Preferred Stock had no expiration date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"The securities reported herein are held of record by Four Pines Master Fund LP (\"Four Pines\"). RSC is the general partner of RSCM which is the investment manager to Four Pines. RSC and RSCM may therefore be deemed to have or share beneficial ownership of the shares held directly by Four Pines."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":152926},"source":{"system":"sec-edgar","filing":"0000899243-21-025312","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1840574/000089924321025312/doc4.xml","form_type":"4"}},{"id":2659202,"issuer":{"id":11259,"kind":"organization","name":"Verve Therapeutics, Inc.","symbol":"VERV"},"owners":[{"id":117967,"kind":"organization","name":"Rock Springs Capital Management LP","position":1,"cik":"0001595725","reported_name":"Rock Springs Capital Management LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":131482,"kind":"organization","name":"Rock Springs Capital Master Fund LP","position":2,"cik":"0001735393","reported_name":"Rock Springs Capital Master Fund LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":131481,"kind":"organization","name":"Rock Springs Capital LLC","position":3,"cik":"0001735397","reported_name":"Rock Springs Capital LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Series B Preferred Stock","published_at":"2021-06-22T17:20:53.000Z","date":"2021-06-21","kind":"exercise","acquired":false,"shares":5151043,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"The Series B Preferred Stock converted into shares of the Issuer's common stock, $0.001 par value, on an approximately 9.2595:1 basis automatically immediately prior to the closing of the Issuer's initial public offering. The Series B Preferred Stock had no expiration date."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The Series B Preferred Stock converted into shares of the Issuer's common stock, $0.001 par value, on an approximately 9.2595:1 basis automatically immediately prior to the closing of the Issuer's initial public offering. The Series B Preferred Stock had no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The Series B Preferred Stock converted into shares of the Issuer's common stock, $0.001 par value, on an approximately 9.2595:1 basis automatically immediately prior to the closing of the Issuer's initial public offering. The Series B Preferred Stock had no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"The Series B Preferred Stock converted into shares of the Issuer's common stock, $0.001 par value, on an approximately 9.2595:1 basis automatically immediately prior to the closing of the Issuer's initial public offering. The Series B Preferred Stock had no expiration date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The securities reported herein are held of record by Rock Springs Capital Master Fund LP (\"Master Fund\"). Rock Springs Capital LLC (\"RSC\") is the general partner of Rock Springs Capital Management LP (\"RSCM\") which is the investment manager to Master Fund. RSC and RSCM may therefore be deemed to have or share beneficial ownership of the shares held directly by Master Fund."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":556298},"source":{"system":"sec-edgar","filing":"0000899243-21-025312","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1840574/000089924321025312/doc4.xml","form_type":"4"}},{"id":2659201,"issuer":{"id":11259,"kind":"organization","name":"Verve Therapeutics, Inc.","symbol":"VERV"},"owners":[{"id":117967,"kind":"organization","name":"Rock Springs Capital Management LP","position":1,"cik":"0001595725","reported_name":"Rock Springs Capital Management LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":131482,"kind":"organization","name":"Rock Springs Capital Master Fund LP","position":2,"cik":"0001735393","reported_name":"Rock Springs Capital Master Fund LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":131481,"kind":"organization","name":"Rock Springs Capital LLC","position":3,"cik":"0001735397","reported_name":"Rock Springs Capital LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2021-06-22T17:20:53.000Z","date":"2021-06-21","kind":"exercise","acquired":true,"shares":152926,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The Series B Preferred Stock converted into shares of the Issuer's common stock, $0.001 par value, on an approximately 9.2595:1 basis automatically immediately prior to the closing of the Issuer's initial public offering. The Series B Preferred Stock had no expiration date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"The securities reported herein are held of record by Four Pines Master Fund LP (\"Four Pines\"). RSC is the general partner of RSCM which is the investment manager to Four Pines. RSC and RSCM may therefore be deemed to have or share beneficial ownership of the shares held directly by Four Pines."}],"balance_after":152926,"source":{"system":"sec-edgar","filing":"0000899243-21-025312","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1840574/000089924321025312/doc4.xml","form_type":"4"}},{"id":2659200,"issuer":{"id":11259,"kind":"organization","name":"Verve Therapeutics, Inc.","symbol":"VERV"},"owners":[{"id":117967,"kind":"organization","name":"Rock Springs Capital Management LP","position":1,"cik":"0001595725","reported_name":"Rock Springs Capital Management LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":131482,"kind":"organization","name":"Rock Springs Capital Master Fund LP","position":2,"cik":"0001735393","reported_name":"Rock Springs Capital Master Fund LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":131481,"kind":"organization","name":"Rock Springs Capital LLC","position":3,"cik":"0001735397","reported_name":"Rock Springs Capital LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2021-06-22T17:20:53.000Z","date":"2021-06-21","kind":"purchase","acquired":true,"shares":370000,"price":19,"value":7030000.0,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The securities reported herein are held of record by Rock Springs Capital Master Fund LP (\"Master Fund\"). Rock Springs Capital LLC (\"RSC\") is the general partner of Rock Springs Capital Management LP (\"RSCM\") which is the investment manager to Master Fund. RSC and RSCM may therefore be deemed to have or share beneficial ownership of the shares held directly by Master Fund."}],"balance_after":926298,"source":{"system":"sec-edgar","filing":"0000899243-21-025312","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1840574/000089924321025312/doc4.xml","form_type":"4"}},{"id":2659199,"issuer":{"id":11259,"kind":"organization","name":"Verve Therapeutics, Inc.","symbol":"VERV"},"owners":[{"id":117967,"kind":"organization","name":"Rock Springs Capital Management LP","position":1,"cik":"0001595725","reported_name":"Rock Springs Capital Management LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":131482,"kind":"organization","name":"Rock Springs Capital Master Fund LP","position":2,"cik":"0001735393","reported_name":"Rock Springs Capital Master Fund LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":131481,"kind":"organization","name":"Rock Springs Capital LLC","position":3,"cik":"0001735397","reported_name":"Rock Springs Capital LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2021-06-22T17:20:53.000Z","date":"2021-06-21","kind":"exercise","acquired":true,"shares":556298,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The Series B Preferred Stock converted into shares of the Issuer's common stock, $0.001 par value, on an approximately 9.2595:1 basis automatically immediately prior to the closing of the Issuer's initial public offering. The Series B Preferred Stock had no expiration date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The securities reported herein are held of record by Rock Springs Capital Master Fund LP (\"Master Fund\"). Rock Springs Capital LLC (\"RSC\") is the general partner of Rock Springs Capital Management LP (\"RSCM\") which is the investment manager to Master Fund. RSC and RSCM may therefore be deemed to have or share beneficial ownership of the shares held directly by Master Fund."}],"balance_after":556298,"source":{"system":"sec-edgar","filing":"0000899243-21-025312","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1840574/000089924321025312/doc4.xml","form_type":"4"}},{"id":2992233,"issuer":{"id":5580,"kind":"organization","name":"Atea Pharmaceuticals, Inc."},"owners":[{"id":117967,"kind":"organization","name":"Rock Springs Capital Management LP","position":1,"cik":"0001595725","reported_name":"Rock Springs Capital Management LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":131482,"kind":"organization","name":"Rock Springs Capital Master Fund LP","position":2,"cik":"0001735393","reported_name":"Rock Springs Capital Master Fund LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":131481,"kind":"organization","name":"Rock Springs Capital LLC","position":3,"cik":"0001735397","reported_name":"Rock Springs Capital LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Series D-1 Convertible Preferred Stock","published_at":"2020-11-04T21:05:12.000Z","date":"2020-11-03","kind":"exercise","acquired":false,"shares":104340,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"The preferred stock was convertible at any time, at the holder's election and had no expiration date. Each share of preferred stock was automatically converted into one share of common stock upon the closing of the Issuer's initial public offering of its common stock."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The preferred stock was convertible at any time, at the holder's election and had no expiration date. Each share of preferred stock was automatically converted into one share of common stock upon the closing of the Issuer's initial public offering of its common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The preferred stock was convertible at any time, at the holder's election and had no expiration date. Each share of preferred stock was automatically converted into one share of common stock upon the closing of the Issuer's initial public offering of its common stock."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"The preferred stock was convertible at any time, at the holder's election and had no expiration date. Each share of preferred stock was automatically converted into one share of common stock upon the closing of the Issuer's initial public offering of its common stock."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"The securities reported herein are held of record by Four Pines Master Fund LP (\"Four Pines\"). RSC is the general partner of RSCM which is the investment manager to Four Pines. RSC and RSCM may therefore be deemed to have or share beneficial ownership of the preferred stock held directly by Four Pines."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":104340},"source":{"system":"sec-edgar","filing":"0000899243-20-030382","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1593899/000089924320030382/doc4.xml","form_type":"4"}},{"id":2992232,"issuer":{"id":5580,"kind":"organization","name":"Atea Pharmaceuticals, Inc."},"owners":[{"id":117967,"kind":"organization","name":"Rock Springs Capital Management LP","position":1,"cik":"0001595725","reported_name":"Rock Springs Capital Management LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":131482,"kind":"organization","name":"Rock Springs Capital Master Fund LP","position":2,"cik":"0001735393","reported_name":"Rock Springs Capital Master Fund LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":131481,"kind":"organization","name":"Rock Springs Capital LLC","position":3,"cik":"0001735397","reported_name":"Rock Springs Capital LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Series D Convertible Preferred Stock","published_at":"2020-11-04T21:05:12.000Z","date":"2020-11-03","kind":"exercise","acquired":false,"shares":178063,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"The preferred stock was convertible at any time, at the holder's election and had no expiration date. Each share of preferred stock was automatically converted into one share of common stock upon the closing of the Issuer's initial public offering of its common stock."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The preferred stock was convertible at any time, at the holder's election and had no expiration date. Each share of preferred stock was automatically converted into one share of common stock upon the closing of the Issuer's initial public offering of its common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The preferred stock was convertible at any time, at the holder's election and had no expiration date. Each share of preferred stock was automatically converted into one share of common stock upon the closing of the Issuer's initial public offering of its common stock."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"The preferred stock was convertible at any time, at the holder's election and had no expiration date. Each share of preferred stock was automatically converted into one share of common stock upon the closing of the Issuer's initial public offering of its common stock."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"The securities reported herein are held of record by Four Pines Master Fund LP (\"Four Pines\"). RSC is the general partner of RSCM which is the investment manager to Four Pines. RSC and RSCM may therefore be deemed to have or share beneficial ownership of the preferred stock held directly by Four Pines."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":178063},"source":{"system":"sec-edgar","filing":"0000899243-20-030382","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1593899/000089924320030382/doc4.xml","form_type":"4"}},{"id":2992231,"issuer":{"id":5580,"kind":"organization","name":"Atea Pharmaceuticals, Inc."},"owners":[{"id":117967,"kind":"organization","name":"Rock Springs Capital Management LP","position":1,"cik":"0001595725","reported_name":"Rock Springs Capital Management LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":131482,"kind":"organization","name":"Rock Springs Capital Master Fund LP","position":2,"cik":"0001735393","reported_name":"Rock Springs Capital Master Fund LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":131481,"kind":"organization","name":"Rock Springs Capital LLC","position":3,"cik":"0001735397","reported_name":"Rock Springs Capital LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Series D-1 Convertible Preferred Stock","published_at":"2020-11-04T21:05:12.000Z","date":"2020-11-03","kind":"exercise","acquired":false,"shares":521703,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"The preferred stock was convertible at any time, at the holder's election and had no expiration date. Each share of preferred stock was automatically converted into one share of common stock upon the closing of the Issuer's initial public offering of its common stock."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The preferred stock was convertible at any time, at the holder's election and had no expiration date. Each share of preferred stock was automatically converted into one share of common stock upon the closing of the Issuer's initial public offering of its common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The preferred stock was convertible at any time, at the holder's election and had no expiration date. Each share of preferred stock was automatically converted into one share of common stock upon the closing of the Issuer's initial public offering of its common stock."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"The preferred stock was convertible at any time, at the holder's election and had no expiration date. Each share of preferred stock was automatically converted into one share of common stock upon the closing of the Issuer's initial public offering of its common stock."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The securities reported herein are held of record by Rock Springs Capital Master Fund LP (\"Master Fund\"). Rock Springs Capital LLC (\"RSC\") is the general partner of Rock Springs Capital Management LP (\"RSCM\") which is the investment manager to Master Fund. RSC and RSCM may therefore be deemed to have or share beneficial ownership of preferred stock held directly by Master Fund."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":521703},"source":{"system":"sec-edgar","filing":"0000899243-20-030382","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1593899/000089924320030382/doc4.xml","form_type":"4"}},{"id":2992230,"issuer":{"id":5580,"kind":"organization","name":"Atea Pharmaceuticals, Inc."},"owners":[{"id":117967,"kind":"organization","name":"Rock Springs Capital Management LP","position":1,"cik":"0001595725","reported_name":"Rock Springs Capital Management LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":131482,"kind":"organization","name":"Rock Springs Capital Master Fund LP","position":2,"cik":"0001735393","reported_name":"Rock Springs Capital Master Fund LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":131481,"kind":"organization","name":"Rock Springs Capital LLC","position":3,"cik":"0001735397","reported_name":"Rock Springs Capital LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Series D Convertible Preferred Stock","published_at":"2020-11-04T21:05:12.000Z","date":"2020-11-03","kind":"exercise","acquired":false,"shares":890313,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"The preferred stock was convertible at any time, at the holder's election and had no expiration date. Each share of preferred stock was automatically converted into one share of common stock upon the closing of the Issuer's initial public offering of its common stock."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The preferred stock was convertible at any time, at the holder's election and had no expiration date. Each share of preferred stock was automatically converted into one share of common stock upon the closing of the Issuer's initial public offering of its common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The preferred stock was convertible at any time, at the holder's election and had no expiration date. Each share of preferred stock was automatically converted into one share of common stock upon the closing of the Issuer's initial public offering of its common stock."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"The preferred stock was convertible at any time, at the holder's election and had no expiration date. Each share of preferred stock was automatically converted into one share of common stock upon the closing of the Issuer's initial public offering of its common stock."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The securities reported herein are held of record by Rock Springs Capital Master Fund LP (\"Master Fund\"). Rock Springs Capital LLC (\"RSC\") is the general partner of Rock Springs Capital Management LP (\"RSCM\") which is the investment manager to Master Fund. RSC and RSCM may therefore be deemed to have or share beneficial ownership of preferred stock held directly by Master Fund."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":890313},"source":{"system":"sec-edgar","filing":"0000899243-20-030382","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1593899/000089924320030382/doc4.xml","form_type":"4"}},{"id":2992229,"issuer":{"id":5580,"kind":"organization","name":"Atea Pharmaceuticals, Inc."},"owners":[{"id":117967,"kind":"organization","name":"Rock Springs Capital Management LP","position":1,"cik":"0001595725","reported_name":"Rock Springs Capital Management LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":131482,"kind":"organization","name":"Rock Springs Capital Master Fund LP","position":2,"cik":"0001735393","reported_name":"Rock Springs Capital Master Fund LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":131481,"kind":"organization","name":"Rock Springs Capital LLC","position":3,"cik":"0001735397","reported_name":"Rock Springs Capital LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2020-11-04T21:05:12.000Z","date":"2020-11-03","kind":"purchase","acquired":true,"shares":7292,"price":24,"value":175008.0,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"The securities reported herein are held of record by Four Pines Master Fund LP (\"Four Pines\"). RSC is the general partner of RSCM which is the investment manager to Four Pines. RSC and RSCM may therefore be deemed to have or share beneficial ownership of the preferred stock held directly by Four Pines."}],"balance_after":289695,"source":{"system":"sec-edgar","filing":"0000899243-20-030382","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1593899/000089924320030382/doc4.xml","form_type":"4"}},{"id":2992228,"issuer":{"id":5580,"kind":"organization","name":"Atea Pharmaceuticals, Inc."},"owners":[{"id":117967,"kind":"organization","name":"Rock Springs Capital Management LP","position":1,"cik":"0001595725","reported_name":"Rock Springs Capital Management LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":131482,"kind":"organization","name":"Rock Springs Capital Master Fund LP","position":2,"cik":"0001735393","reported_name":"Rock Springs Capital Master Fund LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":131481,"kind":"organization","name":"Rock Springs Capital LLC","position":3,"cik":"0001735397","reported_name":"Rock Springs Capital LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2020-11-04T21:05:12.000Z","date":"2020-11-03","kind":"purchase","acquired":true,"shares":242708,"price":24,"value":5824992.0,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The securities reported herein are held of record by Rock Springs Capital Master Fund LP (\"Master Fund\"). Rock Springs Capital LLC (\"RSC\") is the general partner of Rock Springs Capital Management LP (\"RSCM\") which is the investment manager to Master Fund. RSC and RSCM may therefore be deemed to have or share beneficial ownership of preferred stock held directly by Master Fund."}],"balance_after":1654724,"source":{"system":"sec-edgar","filing":"0000899243-20-030382","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1593899/000089924320030382/doc4.xml","form_type":"4"}},{"id":2992227,"issuer":{"id":5580,"kind":"organization","name":"Atea Pharmaceuticals, Inc."},"owners":[{"id":117967,"kind":"organization","name":"Rock Springs Capital Management LP","position":1,"cik":"0001595725","reported_name":"Rock Springs Capital Management LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":131482,"kind":"organization","name":"Rock Springs Capital Master Fund LP","position":2,"cik":"0001735393","reported_name":"Rock Springs Capital Master Fund LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":131481,"kind":"organization","name":"Rock Springs Capital LLC","position":3,"cik":"0001735397","reported_name":"Rock Springs Capital LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2020-11-04T21:05:12.000Z","date":"2020-11-03","kind":"exercise","acquired":true,"shares":282403,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The preferred stock was convertible at any time, at the holder's election and had no expiration date. Each share of preferred stock was automatically converted into one share of common stock upon the closing of the Issuer's initial public offering of its common stock."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"The securities reported herein are held of record by Four Pines Master Fund LP (\"Four Pines\"). RSC is the general partner of RSCM which is the investment manager to Four Pines. RSC and RSCM may therefore be deemed to have or share beneficial ownership of the preferred stock held directly by Four Pines."}],"balance_after":282403,"source":{"system":"sec-edgar","filing":"0000899243-20-030382","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1593899/000089924320030382/doc4.xml","form_type":"4"}},{"id":2992226,"issuer":{"id":5580,"kind":"organization","name":"Atea Pharmaceuticals, Inc."},"owners":[{"id":117967,"kind":"organization","name":"Rock Springs Capital Management LP","position":1,"cik":"0001595725","reported_name":"Rock Springs Capital Management LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":131482,"kind":"organization","name":"Rock Springs Capital Master Fund LP","position":2,"cik":"0001735393","reported_name":"Rock Springs Capital Master Fund LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":131481,"kind":"organization","name":"Rock Springs Capital LLC","position":3,"cik":"0001735397","reported_name":"Rock Springs Capital LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2020-11-04T21:05:12.000Z","date":"2020-11-03","kind":"exercise","acquired":true,"shares":1412016,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The preferred stock was convertible at any time, at the holder's election and had no expiration date. Each share of preferred stock was automatically converted into one share of common stock upon the closing of the Issuer's initial public offering of its common stock."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The securities reported herein are held of record by Rock Springs Capital Master Fund LP (\"Master Fund\"). Rock Springs Capital LLC (\"RSC\") is the general partner of Rock Springs Capital Management LP (\"RSCM\") which is the investment manager to Master Fund. RSC and RSCM may therefore be deemed to have or share beneficial ownership of preferred stock held directly by Master Fund."}],"balance_after":1412016,"source":{"system":"sec-edgar","filing":"0000899243-20-030382","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1593899/000089924320030382/doc4.xml","form_type":"4"}},{"id":3074912,"issuer":{"id":77717,"kind":"organization","name":"Inozyme Pharma, Inc.","symbol":"INZY"},"owners":[{"id":117967,"kind":"organization","name":"Rock Springs Capital Management LP","position":1,"cik":"0001595725","reported_name":"Rock Springs Capital Management LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":131482,"kind":"organization","name":"Rock Springs Capital Master Fund LP","position":2,"cik":"0001735393","reported_name":"Rock Springs Capital Master Fund LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":131481,"kind":"organization","name":"Rock Springs Capital LLC","position":3,"cik":"0001735397","reported_name":"Rock Springs Capital LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Series A-2 Convertible Preferred Stock","published_at":"2020-07-28T20:53:13.000Z","date":"2020-07-28","kind":"exercise","acquired":false,"shares":3496504,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"On July 28, 2020, the Series A-2 Convertible Preferred Stock automatically converted into Common Stock on a 7.4730-for-1 basis upon the closing of the Issuer's initial public offering without payment of consideration. The Series A-2 Convertible Preferred Stock was convertible at any time at the holder's election and automatically upon the closing of the Issuer's initial public offering. The shares had no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"On July 28, 2020, the Series A-2 Convertible Preferred Stock automatically converted into Common Stock on a 7.4730-for-1 basis upon the closing of the Issuer's initial public offering without payment of consideration. The Series A-2 Convertible Preferred Stock was convertible at any time at the holder's election and automatically upon the closing of the Issuer's initial public offering. The shares had no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"On July 28, 2020, the Series A-2 Convertible Preferred Stock automatically converted into Common Stock on a 7.4730-for-1 basis upon the closing of the Issuer's initial public offering without payment of consideration. The Series A-2 Convertible Preferred Stock was convertible at any time at the holder's election and automatically upon the closing of the Issuer's initial public offering. The shares had no expiration date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The securities reported herein are held of record by Rock Springs Capital Master Fund LP (\"Master Fund\"). Rock Springs Capital LLC (\"RSC\") is the general partner of Rock Springs Capital Management LP (\"RSCM\") which is the investment manager to Master Fund. RSC and RSCM may therefore be deemed to have or share beneficial ownership of the Common Stock held directly by Master Fund."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":467884},"source":{"system":"sec-edgar","filing":"0000899243-20-020576","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1693011/000089924320020576/doc4.xml","form_type":"4"}},{"id":3074911,"issuer":{"id":77717,"kind":"organization","name":"Inozyme Pharma, Inc.","symbol":"INZY"},"owners":[{"id":117967,"kind":"organization","name":"Rock Springs Capital Management LP","position":1,"cik":"0001595725","reported_name":"Rock Springs Capital Management LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":131482,"kind":"organization","name":"Rock Springs Capital Master Fund LP","position":2,"cik":"0001735393","reported_name":"Rock Springs Capital Master Fund LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":131481,"kind":"organization","name":"Rock Springs Capital LLC","position":3,"cik":"0001735397","reported_name":"Rock Springs Capital LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2020-07-28T20:53:13.000Z","date":"2020-07-28","kind":"purchase","acquired":true,"shares":24000,"price":16,"value":384000.0,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"The securities reported herein are held of record by Four Pines Master Fund LP. RSC is the general partner of RSCM which is the investment manager to Four Pines Master Fund LP. RSC and RSCM may therefore be deemed to have or share beneficial ownership of the Common Stock held directly by Four Pines Master Fund LP."}],"balance_after":1067884,"source":{"system":"sec-edgar","filing":"0000899243-20-020576","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1693011/000089924320020576/doc4.xml","form_type":"4"}},{"id":3074910,"issuer":{"id":77717,"kind":"organization","name":"Inozyme Pharma, Inc.","symbol":"INZY"},"owners":[{"id":117967,"kind":"organization","name":"Rock Springs Capital Management LP","position":1,"cik":"0001595725","reported_name":"Rock Springs Capital Management LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":131482,"kind":"organization","name":"Rock Springs Capital Master Fund LP","position":2,"cik":"0001735393","reported_name":"Rock Springs Capital Master Fund LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":131481,"kind":"organization","name":"Rock Springs Capital LLC","position":3,"cik":"0001735397","reported_name":"Rock Springs Capital LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2020-07-28T20:53:13.000Z","date":"2020-07-28","kind":"purchase","acquired":true,"shares":576000,"price":16,"value":9216000.0,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The securities reported herein are held of record by Rock Springs Capital Master Fund LP (\"Master Fund\"). Rock Springs Capital LLC (\"RSC\") is the general partner of Rock Springs Capital Management LP (\"RSCM\") which is the investment manager to Master Fund. RSC and RSCM may therefore be deemed to have or share beneficial ownership of the Common Stock held directly by Master Fund."}],"balance_after":1043884,"source":{"system":"sec-edgar","filing":"0000899243-20-020576","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1693011/000089924320020576/doc4.xml","form_type":"4"}},{"id":3074909,"issuer":{"id":77717,"kind":"organization","name":"Inozyme Pharma, Inc.","symbol":"INZY"},"owners":[{"id":117967,"kind":"organization","name":"Rock Springs Capital Management LP","position":1,"cik":"0001595725","reported_name":"Rock Springs Capital Management LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":131482,"kind":"organization","name":"Rock Springs Capital Master Fund LP","position":2,"cik":"0001735393","reported_name":"Rock Springs Capital Master Fund LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":131481,"kind":"organization","name":"Rock Springs Capital LLC","position":3,"cik":"0001735397","reported_name":"Rock Springs Capital LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2020-07-28T20:53:13.000Z","date":"2020-07-28","kind":"exercise","acquired":true,"shares":467884,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"On July 28, 2020, the Series A-2 Convertible Preferred Stock automatically converted into Common Stock on a 7.4730-for-1 basis upon the closing of the Issuer's initial public offering without payment of consideration. The Series A-2 Convertible Preferred Stock was convertible at any time at the holder's election and automatically upon the closing of the Issuer's initial public offering. The shares had no expiration date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The securities reported herein are held of record by Rock Springs Capital Master Fund LP (\"Master Fund\"). Rock Springs Capital LLC (\"RSC\") is the general partner of Rock Springs Capital Management LP (\"RSCM\") which is the investment manager to Master Fund. RSC and RSCM may therefore be deemed to have or share beneficial ownership of the Common Stock held directly by Master Fund."}],"balance_after":467884,"source":{"system":"sec-edgar","filing":"0000899243-20-020576","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1693011/000089924320020576/doc4.xml","form_type":"4"}},{"id":3208905,"issuer":{"id":4024,"kind":"organization","name":"Enliven Therapeutics, Inc.","symbol":"ELVN"},"owners":[{"id":117967,"kind":"organization","name":"Rock Springs Capital Management LP","position":1,"cik":"0001595725","reported_name":"Rock Springs Capital Management LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":131482,"kind":"organization","name":"Rock Springs Capital Master Fund LP","position":2,"cik":"0001735393","reported_name":"Rock Springs Capital Master Fund LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":131481,"kind":"organization","name":"Rock Springs Capital LLC","position":3,"cik":"0001735397","reported_name":"Rock Springs Capital LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Series B Preferred Stock","published_at":"2020-03-16T21:04:56.000Z","date":"2020-03-16","kind":"exercise","acquired":false,"shares":1722222,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"On March 16, 2020, the Issuer's Series B Preferred Stock converted into Common Stock on a 6.299-for-1 basis upon the closing of the Issuer's initial public offering without payment of consideration. The Series B Preferred Stock was convertible at any time at the holder's election and automatically upon the closing of the Issuer's initial public offering. The shares had no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"On March 16, 2020, the Issuer's Series B Preferred Stock converted into Common Stock on a 6.299-for-1 basis upon the closing of the Issuer's initial public offering without payment of consideration. The Series B Preferred Stock was convertible at any time at the holder's election and automatically upon the closing of the Issuer's initial public offering. The shares had no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"On March 16, 2020, the Issuer's Series B Preferred Stock converted into Common Stock on a 6.299-for-1 basis upon the closing of the Issuer's initial public offering without payment of consideration. The Series B Preferred Stock was convertible at any time at the holder's election and automatically upon the closing of the Issuer's initial public offering. The shares had no expiration date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The securities reported herein are held of record by Rock Springs Capital Master Fund LP (\"Master Fund\"). Rock Springs Capital LLC (\"RSC\") is the general partner of Rock Springs Capital Management LP (\"RSCM\") which is the investment manager to Master Fund. RSC and RSCM may therefore be deemed to have or share beneficial ownership of the Series B Preferred Stock held directly by Master Fund."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":273411},"source":{"system":"sec-edgar","filing":"0000899243-20-008475","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1672619/000089924320008475/doc4.xml","form_type":"4"}},{"id":3208904,"issuer":{"id":4024,"kind":"organization","name":"Enliven Therapeutics, Inc.","symbol":"ELVN"},"owners":[{"id":117967,"kind":"organization","name":"Rock Springs Capital Management LP","position":1,"cik":"0001595725","reported_name":"Rock Springs Capital Management LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":131482,"kind":"organization","name":"Rock Springs Capital Master Fund LP","position":2,"cik":"0001735393","reported_name":"Rock Springs Capital Master Fund LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":131481,"kind":"organization","name":"Rock Springs Capital LLC","position":3,"cik":"0001735397","reported_name":"Rock Springs Capital LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2020-03-16T21:04:56.000Z","date":"2020-03-16","kind":"purchase","acquired":true,"shares":250000,"price":16,"value":4000000.0,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The securities reported herein are held of record by Rock Springs Capital Master Fund LP (\"Master Fund\"). Rock Springs Capital LLC (\"RSC\") is the general partner of Rock Springs Capital Management LP (\"RSCM\") which is the investment manager to Master Fund. RSC and RSCM may therefore be deemed to have or share beneficial ownership of the Series B Preferred Stock held directly by Master Fund."}],"balance_after":523411,"source":{"system":"sec-edgar","filing":"0000899243-20-008475","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1672619/000089924320008475/doc4.xml","form_type":"4"}},{"id":3208903,"issuer":{"id":4024,"kind":"organization","name":"Enliven Therapeutics, Inc.","symbol":"ELVN"},"owners":[{"id":117967,"kind":"organization","name":"Rock Springs Capital Management LP","position":1,"cik":"0001595725","reported_name":"Rock Springs Capital Management LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":131482,"kind":"organization","name":"Rock Springs Capital Master Fund LP","position":2,"cik":"0001735393","reported_name":"Rock Springs Capital Master Fund LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":131481,"kind":"organization","name":"Rock Springs Capital LLC","position":3,"cik":"0001735397","reported_name":"Rock Springs Capital LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2020-03-16T21:04:56.000Z","date":"2020-03-16","kind":"exercise","acquired":true,"shares":273411,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"On March 16, 2020, the Issuer's Series B Preferred Stock converted into Common Stock on a 6.299-for-1 basis upon the closing of the Issuer's initial public offering without payment of consideration. The Series B Preferred Stock was convertible at any time at the holder's election and automatically upon the closing of the Issuer's initial public offering. The shares had no expiration date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The securities reported herein are held of record by Rock Springs Capital Master Fund LP (\"Master Fund\"). Rock Springs Capital LLC (\"RSC\") is the general partner of Rock Springs Capital Management LP (\"RSCM\") which is the investment manager to Master Fund. RSC and RSCM may therefore be deemed to have or share beneficial ownership of the Series B Preferred Stock held directly by Master Fund."}],"balance_after":273411,"source":{"system":"sec-edgar","filing":"0000899243-20-008475","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1672619/000089924320008475/doc4.xml","form_type":"4"}},{"id":3969045,"issuer":{"id":5594,"kind":"organization","name":"Q32 Bio Inc.","symbol":"QTTB"},"owners":[{"id":117967,"kind":"organization","name":"Rock Springs Capital Management LP","position":1,"cik":"0001595725","reported_name":"Rock Springs Capital Management LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":131482,"kind":"organization","name":"Rock Springs Capital Master Fund LP","position":2,"cik":"0001735393","reported_name":"Rock Springs Capital Master Fund LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":131481,"kind":"organization","name":"Rock Springs Capital LLC","position":3,"cik":"0001735397","reported_name":"Rock Springs Capital LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Series B Preferred Stock","published_at":"2018-04-04T20:24:07.000Z","date":"2018-04-02","kind":"exercise","acquired":false,"shares":395845,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Upon closing of the Issuer's initial public offering, each share of preferred stock was automatically converted into one share of the Issuer's common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Upon closing of the Issuer's initial public offering, each share of preferred stock was automatically converted into one share of the Issuer's common stock."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"Upon closing of the Issuer's initial public offering, each share of preferred stock was automatically converted into one share of the Issuer's common stock."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"The securities reported herein are held of record by Rock Springs Capital Master Fund LP (\"Master Fund\"). Rock Springs Capital LLC (\"RSC\") is the general partner of Rock Springs Capital Management LP (\"RSCM\") which is the investment manager to Master Fund. RSC and RSCM may therefore be deemed to have or share beneficial ownership of the securities held directly by Master Fund."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":395845},"source":{"system":"sec-edgar","filing":"0000899243-18-009442","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1595725/000089924318009442/doc4.xml","form_type":"4"}},{"id":3969044,"issuer":{"id":5594,"kind":"organization","name":"Q32 Bio Inc.","symbol":"QTTB"},"owners":[{"id":117967,"kind":"organization","name":"Rock Springs Capital Management LP","position":1,"cik":"0001595725","reported_name":"Rock Springs Capital Management LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":131482,"kind":"organization","name":"Rock Springs Capital Master Fund LP","position":2,"cik":"0001735393","reported_name":"Rock Springs Capital Master Fund LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":131481,"kind":"organization","name":"Rock Springs Capital LLC","position":3,"cik":"0001735397","reported_name":"Rock Springs Capital LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2018-04-04T20:24:07.000Z","date":"2018-04-02","kind":"purchase","acquired":true,"shares":250000,"price":16,"value":4000000.0,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"The securities reported herein are held of record by Rock Springs Capital Master Fund LP (\"Master Fund\"). Rock Springs Capital LLC (\"RSC\") is the general partner of Rock Springs Capital Management LP (\"RSCM\") which is the investment manager to Master Fund. RSC and RSCM may therefore be deemed to have or share beneficial ownership of the securities held directly by Master Fund."}],"balance_after":645845,"source":{"system":"sec-edgar","filing":"0000899243-18-009442","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1595725/000089924318009442/doc4.xml","form_type":"4"}},{"id":3969043,"issuer":{"id":5594,"kind":"organization","name":"Q32 Bio Inc.","symbol":"QTTB"},"owners":[{"id":117967,"kind":"organization","name":"Rock Springs Capital Management LP","position":1,"cik":"0001595725","reported_name":"Rock Springs Capital Management LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":131482,"kind":"organization","name":"Rock Springs Capital Master Fund LP","position":2,"cik":"0001735393","reported_name":"Rock Springs Capital Master Fund LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":131481,"kind":"organization","name":"Rock Springs Capital LLC","position":3,"cik":"0001735397","reported_name":"Rock Springs Capital LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2018-04-04T20:24:07.000Z","date":"2018-04-02","kind":"exercise","acquired":true,"shares":395845,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"The securities reported herein are held of record by Rock Springs Capital Master Fund LP (\"Master Fund\"). Rock Springs Capital LLC (\"RSC\") is the general partner of Rock Springs Capital Management LP (\"RSCM\") which is the investment manager to Master Fund. RSC and RSCM may therefore be deemed to have or share beneficial ownership of the securities held directly by Master Fund."}],"balance_after":395845,"source":{"system":"sec-edgar","filing":"0000899243-18-009442","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1595725/000089924318009442/doc4.xml","form_type":"4"}}]}